| Enid Leikin, MD | |
|
15 N Broadway, White Plains, NY 10601-2214 | |
| (914) 328-8444 | |
| (914) 328-8414 |
| Full Name | Enid Leikin |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology - Maternal & Fetal Medicine |
| Location | 15 N Broadway, White Plains, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538150057 | NPI | - | NPPES |
| 01074895 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 147239 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Enid Leikin, MD 15 N Broadway, White Plains, NY 10601-2214 Ph: (914) 328-8444 | Enid Leikin, MD 15 N Broadway, White Plains, NY 10601-2214 Ph: (914) 328-8444 |
News Archive
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S.
Major metropolitan areas show significant variation in the rates of emergency department (ED) visits involving illicit drugs.
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
› Verified 3 days ago
Juan Carlos Rojas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 Greenridge Ave, Suite 302, White Plains, NY 10605 Phone: 914-937-6085 Fax: 914-934-3253 | |
Subodh K Datta, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 Tarrytown Rd, White Plains, NY 10607 Phone: 914-989-7600 Fax: 914-285-4991 | |
Dr. Aurora Leibold, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-0732 | |
Dr. Rebecca Ann Kleban, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-831-6800 Fax: 914-831-6801 | |
Dr. Fernando Temporal Mariz, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 222 Mamaroneck Ave, White Plains, NY 10605 Phone: 914-946-0050 | |
Dr. Janice Renee Crowder, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 41 E Post Rd, White Plains, NY 10601 Phone: 914-681-0600 Fax: 914-681-2912 | |
Dr. Lawrence John Severino, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 200 Saxon Woods Rd, White Plains, NY 10605 Phone: 914-949-6344 Fax: 914-948-5563 |